Publicaciones en colaboración con investigadores/as de AstraZeneca (United Kingdom) (2)

2009

  1. Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: A multicenter, prospective, and naturalistic study

    Journal of Clinical Psychiatry, Vol. 70, Núm. 4, pp. 509-517

2008

  1. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia

    International Clinical Psychopharmacology, Vol. 23, Núm. 3, pp. 138-149